Status:

COMPLETED

The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial

Lead Sponsor:

Noor Taha Ismaeel

Conditions:

Hemangioma

Eligibility:

All Genders

5-60 years

Phase:

NA

Brief Summary

In an academic, government clinic, uni-center, randomized within patients trial study of the effects of 980-nm diode laser treatment included 15 cases of facial hemangiomas in patients with a history ...

Eligibility Criteria

Inclusion

  • Comfortable.
  • Superficial lesion.

Exclusion

  • Advanced case.
  • Deep lesion.
  • Uncomfortable.

Key Trial Info

Start Date :

October 14 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2019

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT04065217

Start Date

October 14 2018

End Date

August 15 2019

Last Update

August 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Laser for Postgraduate Studies

Baghdad, Iraq, 10001